S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Arcus Biosciences (RCUS) Earnings Date, Estimates & Call Transcripts

$16.29
-0.29 (-1.75%)
(As of 04/15/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 21)
-$1.08 Beat By $0.01
Consensus EPS
(Feb. 21)
-$1.09
Skip Charts & View Estimated and Actual Earnings Data

RCUS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCUS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arcus Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.72)($0.72)($0.72)
Q2 20241($0.71)($0.71)($0.71)
Q3 20241($0.74)($0.74)($0.74)
Q4 20241($0.77)($0.77)($0.77)
FY 20244($2.94)($2.94)($2.94)

RCUS Earnings Date and Information

Arcus Biosciences last released its quarterly earnings data on February 21st, 2024. The reported ($1.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.09) by $0.01. The business had revenue of $31 million for the quarter, compared to analyst estimates of $28.30 million. Its quarterly revenue was down 8.8% on a year-over-year basis. Arcus Biosciences has generated ($4.15) earnings per share over the last year (($4.15) diluted earnings per share). Earnings for Arcus Biosciences are expected to remain at ($3.59) per share in the coming year. Arcus Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Arcus Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/21/2024Q4 2023($1.09)($1.08)+$0.01($1.08)$28.30 million$31.00 million      
11/7/2023Q3 2023($1.12)($0.94)+$0.18($0.94)$27.57 million$32.00 million    
8/7/2023Q2 2023($1.10)($1.04)+$0.06($1.04)$31.81 million$29.00 million
5/9/2023Q1 2023($1.06)($1.09)($0.03)($1.09)$22.47 million$25.00 million
2/28/2023Q4 2022($0.99)($0.93)+$0.06($0.93)$23.43 million$34.00 million
11/2/2022Q3 2022($1.05)($0.90)+$0.15($0.90)$18.26 million$33.58 million
8/3/2022Q2 2022($0.93)($0.93)-($0.93)$21.00 million$26.76 million
5/9/2022Q1 2022$0.83($0.96)($1.79)($0.96)$163.47 million$18.01 million
2/23/2022Q4 2021($1.13)$3.71+$4.84$3.71$8.87 million$354.50 million
11/8/2021Q3 2021($1.13)($1.11)+$0.02($1.11)$9.27 million$9.46 million
8/4/2021Q2 2021($0.87)($1.09)($0.22)($1.09)$18.43 million$9.46 million  
5/4/2021Q1 2021($0.86)($1.08)($0.22)($1.08)$18.80 million$9.46 million

Arcus Biosciences Earnings - Frequently Asked Questions

When is Arcus Biosciences's earnings date?

Arcus Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on RCUS's earnings history.

Did Arcus Biosciences beat their earnings estimates last quarter?

In the previous quarter, Arcus Biosciences (NYSE:RCUS) reported ($1.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.09) by $0.01. Learn more on analysts' earnings estimate vs. RCUS's actual earnings.

How can I listen to Arcus Biosciences's earnings conference call?

The conference call for Arcus Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Arcus Biosciences's conference call transcript?

The conference call transcript for Arcus Biosciences's latest earnings report can be read online. Read Transcript

How can I view Arcus Biosciences's earnings report?

Arcus Biosciences's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Arcus Biosciences generate each year?

Arcus Biosciences (NYSE:RCUS) has a recorded annual revenue of $117 million.

How much profit does Arcus Biosciences generate each year?

Arcus Biosciences (NYSE:RCUS) has a recorded net income of -$307 million. RCUS has generated -$4.15 earnings per share over the last four quarters.

What is Arcus Biosciences's EPS forecast for next year?

Arcus Biosciences's earnings are expected to stay at ($3.59) per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:RCUS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners